Lercapin

Lercanidipine Hydrochloride, the active ingredient in Lercapin, is a calcium channel blocker presented as an oral tablet for oral use. It is indicated for the treatment of hypertension in adult patients. Lercapin works by relaxing vascular smooth muscle, thereby lowering systemic blood pressure.

GNH USA supplies Lercapin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lercapin, a calcium channel blocker, is employed in the management of elevated blood pressure conditions.

Essential hypertension: reduces systemic vascular resistance to achieve target blood pressure. Primary hypertension: provides sustained blood pressure control. Isolated systolic hypertension: lowers systolic pressure while maintaining diastolic stability.

Lercapin may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of ankles or feet. - Dizziness: sensation of light‑headedness, especially after standing. - Tachycardia: increased heart rate. - Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Angioedema: swelling of face, lips, or throat. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Allergic reactions: rash, itching, or anaphylaxis. - Myocardial infarction: rare occurrence of heart attack. - Arrhythmia: irregular heart rhythm.

Before initiating therapy, certain precautions should be observed. - Blood pressure monitoring: assess baseline and follow‑up readings. - Gradual dose adjustment: avoid abrupt changes to prevent hypotension. - Hepatic impairment: use with caution; dose may need adjustment. - Elderly patients: monitor for increased sensitivity to side effects. - Concomitant CYP3A4 inhibitors: evaluate for potential drug accumulation. - Pregnancy: only if benefits outweigh risks; consult a physician. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Lercapin can interact with several drug classes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations. - Concurrent use with other antihypertensives: additive hypotensive effect. - Grapefruit juice: can elevate drug levels.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance diuretic‑induced electrolyte shifts. - Beta‑blockers: risk of excessive bradycardia. - Lithium: possible increase in lithium serum levels.